Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 12    exchanges : Nasdaq    save search
Quantum Software is the Linchpin for Quantum Adoption
Published: 2021-11-12 (Crawled : 12:27) - quantumcomputinginc.com
QUBT | News | $0.752 -0.66% -2.26% 820K twitter stocktwits trandingview |
Information
 | | O: 1.1% H: 0.27% C: -1.24%
software
Akero Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
Published: 2021-11-12 (Crawled : 00:20) - ir.akerotx.com
AKRO | $20.26 -3.52% -3.81% 630K twitter stocktwits trandingview |
Health Technology
 | | O: 0.69% H: 0.0% C: 0.0%
financial results results
Sensei Biotherapeutics Presents Preclinical Data for SNS-101, a pH-Selective Anti-VISTA Antibody, at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-11-12 (Crawled : 16:20) - investors.senseibio.com
SNSE | $0.9917 -0.6% -3.93% 55K twitter stocktwits trandingview |
| | O: -1.15% H: 0.0% C: 0.0%
preclinical immunotherapy therapy cancer antibody iot pre-clinical
S&P Dow Jones Indices Announces Dow Jones Sustainability Indices 2021 Review Results
Published: 2021-11-12 (Crawled : 00:20) - prnewswire.com
MDT | $80.38 -1.12% -0.03% 5M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
SPGI | News | $413.28 0.01% 0.26% 2.8M twitter stocktwits trandingview |
Commercial Services
 | Email alert Add to watchlist
TTFNF | $73.47 1.73% -3.76% 1K twitter stocktwits trandingview |
Energy Minerals
 | Email alert Add to watchlist
results
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2021 Results and Provides Business Update
Published: 2021-11-12 (Crawled : 00:20) - prnewswire.com
ACXP | $2.03 -0.49% -2.29% 17K twitter stocktwits trandingview |
Professional, Scientific, and T...
 | Email alert Add to watchlist
results
Military Streaming Platform Veteran Entertainment Television "VET Tv" Announces Waco Hoover as Chief Executive Officer and Todd Brockman as Chairman of the Board
Published: 2021-11-12 (Crawled : 00:20) - prnewswire.com
VIVEF | $10.775 4.11% -15.36% 0 twitter stocktwits trandingview |
Consumer Services
 | Email alert Add to watchlist
LVS | $45.84 -0.37% 0.11% 6.7M twitter stocktwits trandingview |
Consumer Services
 | Email alert Add to watchlist
VIVHY | $10.61 -0.75% 6.01% 11K twitter stocktwits trandingview |
Utilities
 | Email alert Add to watchlist
platform
Willamette Valley Vineyards Posts results for Q3 2021
Published: 2021-11-12 (Crawled : 00:20) - prnewswire.com
WVVI | $4.715 4.26% 5.57% 3.3K twitter stocktwits trandingview |
Consumer Non-Durables
 | Email alert Add to watchlist
results
Celularity Reports Third Quarter 2021 Financial Results and Corporate Update
Published: 2021-11-12 (Crawled : 00:20) - globenewswire.com
ONCT | $8.545 -2.51% -0.11% 1.6K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
CELU | News 4 | $3.38 5.3% 5.17% 36K twitter stocktwits trandingview |
| Email alert Add to watchlist
financial results results
Usio to Participate in the Ladenburg Thalmann Virtual Technology Expo on November 18th
Published: 2021-11-12 (Crawled : 00:20) - globenewswire.com
USIO 4 | $1.495 1.01% 0.67% 27K twitter stocktwits trandingview |
Commercial Services
 | Email alert Add to watchlist
technology
CLPS CHAIRMAN SPEAKS MILESTONES AND ACHIEVEMENTS IN OVERSEAS BUSINESS DEVELOPMENT AT SHANGHAI FORUM ON SOFTWARE TRADE 2021
Published: 2021-11-12 (Crawled : 00:20) - clpsglobal.com
CLPS | $0.96 -1.03% 2.02% 20K twitter stocktwits trandingview |
Technology Services
 | | O: 0.0% H: 3.18% C: 1.59%
software milestone
Rezolute Reports First Quarter Fiscal 2022 Financial Results and Highlights Recent Company Progress
Published: 2021-11-12 (Crawled : 00:20) - globenewswire.com
RZLT 4 | $2.89 1.05% 1.72% 340K twitter stocktwits trandingview |
Technology Services
 | Email alert Add to watchlist
financial results results
CPaaS vs. UCaaS: How to tell the difference
Published: 2021-11-12 (Crawled : 00:20) - bandwidth.com
BAND 4 | $18.45 1.65% 1.57% 210K twitter stocktwits trandingview |
Commercial Services
 | Email alert Add to watchlist
Psychemedics Corporation Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Quarter 2021
Published: 2021-11-12 (Crawled : 00:20) - globenewswire.com
PMD | $2.645 2.27% 5.54% 1.4K twitter stocktwits trandingview |
Health Services
 | Email alert Add to watchlist
growth
Power Solutions International Announces Third Quarter 2021 Financial Results
Published: 2021-11-12 (Crawled : 00:20) - globenewswire.com
PSIX | $2.25 2.27% 56.25% 3.8K twitter stocktwits trandingview |
Manufacturing
 | Email alert Add to watchlist
financial results results
The Flowr Corporation Announces Third Quarter 2021 Earnings Date
Published: 2021-11-12 (Crawled : 00:20) - globenewswire.com
FLWPF | $0.0189 twitter stocktwits trandingview |
Process Industries
 | Email alert Add to watchlist
Acasti Pharma Announces Annual Stock Option Grants
Published: 2021-11-12 (Crawled : 00:20) - globenewswire.com
ACST | $2.9 0.69% 0.69% 8.4K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
granted grant pharma
Compugen Presents Initial Translational Data Supporting the Differentiation of PVRIG Compared to TIGIT and PD-1 as a Novel Checkpoint on the DNAM Axis at SITC 2021
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K twitter stocktwits trandingview |
Health Technology
 | | O: -10.51% H: 0.0% C: 0.0%
pvrig
Apellis Reiterates Plans to Submit a New Drug Application in the First Half of 2022 for Pegcetacoplan for Geographic Atrophy Following FDA Feedback
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
APLS G | $49.93 2.48% 2.25% 1.2M twitter stocktwits trandingview |
Health Technology
 | | O: 7.31% H: 5.57% C: 4.02%
new drug fda application drug
Scholar Rock Presents Data from Part A of the DRAGON Phase 1 Trial Evaluating SRK-181 as Monotherapy and in Combination with Anti-PD-(L)1 for the Treatment of Solid Tumors -- Announces Advancement into Part B
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
SRRK 4 | $14.09 -4.73% -4.82% 430K twitter stocktwits trandingview |
Health Technology
 | | O: -0.35% H: 3.45% C: 2.09%
treatment solid tumors phase 1 therapy trial
Oncorus Reports Initial Safety, Tolerability, Immune Activation and Positive Clinical Response Data from its Ongoing Phase 1 Clinical Study of ONCR-177, its Lead Viral Immunotherapy Candidate, at SITC 2021
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
ONCR | $0.126 -75.95% 140K twitter stocktwits trandingview |
Health Technology
 | | O: -35.41% H: 1.67% C: -15.76%
immunotherapy ongoing phase 1 positive therapy
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M twitter stocktwits trandingview |
Consumer Services
BOF | $2.08 77.78% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.54 12.27% 40.62% 3.7M twitter stocktwits trandingview |

LICN | $0.999 78.39% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.4 70.0% 39.58% 70M twitter stocktwits trandingview |
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M twitter stocktwits trandingview |
Technology Services
WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services
AIH | $0.458 14.5% 30.92% 91K twitter stocktwits trandingview |
Health Services
WHLM | $6.25 35.87% 28.46% 700K twitter stocktwits trandingview |
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M twitter stocktwits trandingview |
Information
Your saved searches
Save your searches and get alerts when important news are released.